Victorian Clinical Genetics Services (VCGS)
Amy Ruscigno is a Clinical Assistant at Victorian Clinical Genetics Services (VCGS) since November 2023, with previous experience as a Research Assistant at Peter MacCallum Cancer Centre from March 2022 to January 2025, contributing to the POETIC trial within the Psychosocial Cancer Genomics Team. Earlier roles include a Research Assistant at VCGS focusing on Mackenzie’s Mission: Australia’s Reproductive Genetic Carrier Screening Program from February 2021 to December 2022, and a Genomics in Society Research Intern at Murdoch Childrens Research Institute in 2019. Academic credentials consist of a Master of Genetic Counselling (expected completion in October 2025), a Genomics and Health degree, and a Bachelor of Biomedicine Honours degree, all from the University of Melbourne, along with a Bachelor's degree in Psychology and Genetics. Prior educational background includes high school at Ivanhoe Grammar School and St Monica's College.
This person is not in any teams
Victorian Clinical Genetics Services (VCGS)
Victorian Clinical Genetics Services (VCGS) is a specialist prenatal, childhood and adult genetics service. We are an Australian not-for-profit subsidiary of Murdoch Children’s Research Institute (MCRI) and one of the largest contributors driving genetic healthcare, research and policy in the country. We marked our 34th anniversary in July 2022 and acknowledge our fantastic donors, funders, supporters and collaborators over this time, including the global genetics community, and the Australian Federal and Victorian State governments. Located on site at The Royal Children’s Hospital (RCH) Melbourne, we provide an integrated genetic consultation, counselling, testing and diagnostic service for children, adults, families, and prospective parents. Our unique service includes the ability to draw on specific expert knowledge from Melbourne Children’s campus partners RCH and The University of Melbourne, providing individuals and families with accessible and high quality healthcare. As a pioneering not-for-profit organisation, all our proceeds go back into translational medical research so that we can continue to develop innovative solutions to complex genetic health challenges.